These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
469 related items for PubMed ID: 15705640
1. Linezolid in the treatment of Gram-positive prosthetic joint infections. Bassetti M, Vitale F, Melica G, Righi E, Di Biagio A, Molfetta L, Pipino F, Cruciani M, Bassetti D. J Antimicrob Chemother; 2005 Mar; 55(3):387-90. PubMed ID: 15705640 [Abstract] [Full Text] [Related]
2. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A. Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [Abstract] [Full Text] [Related]
7. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections]. Pulay I, Konkoly TM, Zsirka KA, Csapó Z, Flautner L, Tihanyi T. Orv Hetil; 2003 Jan 05; 144(1):29-33. PubMed ID: 12635350 [Abstract] [Full Text] [Related]
8. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA). Bassetti M, Di Biagio A, Cenderello G, Del Bono V, Palermo A, Cruciani M, Bassetti D. J Infect; 2001 Aug 05; 43(2):148-9. PubMed ID: 11676523 [Abstract] [Full Text] [Related]
12. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB. Pediatr Infect Dis J; 2003 Sep 05; 22(9 Suppl):S158-63. PubMed ID: 14520141 [Abstract] [Full Text] [Related]
13. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Chien JW, Kucia ML, Salata RA. Clin Infect Dis; 2000 Jan 05; 30(1):146-51. PubMed ID: 10619743 [Abstract] [Full Text] [Related]
16. Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections. Nguyen S, Pasquet A, Legout L, Beltrand E, Dubreuil L, Migaud H, Yazdanpanah Y, Senneville E. Clin Microbiol Infect; 2009 Dec 05; 15(12):1163-9. PubMed ID: 19438638 [Abstract] [Full Text] [Related]
17. Linezolid for the treatment of infections caused by Gram-positive pathogens in China. Lin DF, Zhang YY, Wu JF, Wang F, Zheng JC, Miao JZ, Zheng LY, Sheng RY, Zhou X, Shen HH, Ijzerman MM, Croos-Dabrera RV, Sheng W. Int J Antimicrob Agents; 2008 Sep 05; 32(3):241-9. PubMed ID: 18635341 [Abstract] [Full Text] [Related]